Reports and Data.jpeg-01
Nucleic Acid Labeling Market To Reach USD 3.08 Billion By 2026 | Reports And Data
December 04, 2019 03:00 ET | Reports and Data
New York, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Increasing healthcare expenditure, rise in disease diagnosis, increase in R&D spending, increase in genomics research, rising demand for personalized...
Reports and Data.jpeg-01
Nucleic Acid Labeling Market To Reach USD 3.08 Billion By 2026 | Reports And Data
December 04, 2019 03:00 ET | Reports and Data
New York, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Increasing healthcare expenditure, rise in disease diagnosis, increase in R&D spending, increase in genomics research, rising demand for personalized...
H.C. Wainwright Reiterates Buy Rating for Co-Diagnostics (NASDAQ:CODX) Following News of Expansion into Africa
October 31, 2019 07:00 ET | BDA International
New York, Oct. 31, 2019 (GLOBE NEWSWIRE) -- H.C. Wainwright has reiterated their “Buy” rating for Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with a patented platform for the development of...
BW Logo.png
Co-Diagnostics, Inc. Continues to Execute on International Expansion
October 29, 2019 06:30 ET | Co-Diagnostics
Salt Lake City, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Salt Lake City, Utah – October 29, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique,...
BW Logo.png
Co-Diagnostics to Present Technology Applications at 4th ACTC Liquid Biopsy Conference in Corfu, Greece
October 03, 2019 06:30 ET | Co-Diagnostics
Salt Lake City, UT, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
BW Logo.png
Co-Diagnostics, Inc. to Launch Vector Control Products into Midwest US at OPMA Conference
September 19, 2019 06:30 ET | Co-Diagnostics
Salt Lake City, UT, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
BW Logo.png
Co-Diagnostics, Inc. and LGC, Biosearch Technologies Expand License Agreement for CoPrimer™ Technology
September 04, 2019 06:30 ET | Co-Diagnostics
Salt Lake City, Utah, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Diagnostics,” or the “Company”), a molecular diagnostics company with a unique, patented platform...
BDA Logo3.jpg
Co-Diagnostics CEO Opens up on Goals and Milestones in Interview with Wall Street Analyzer
August 29, 2019 07:00 ET | BDA International
New York City, New York, Aug. 29, 2019 (GLOBE NEWSWIRE) -- The Wall Street Analyzer recently completed and published an interview with the CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular...
BW Logo.png
Co-Diagnostics, Inc. to Present at 21st Annual Rodman & Renshaw Global Investment Conference Sept 8-10, 2019
August 28, 2019 06:30 ET | Co-Diagnostics
Salt Lake City, Utah, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
BW Logo.png
Co-Diagnostics, Inc. to Host 2nd Semiannual Distributor Conference on Sept 10-12
August 21, 2019 06:30 ET | Co-Diagnostics
Salt Lake City, Utah, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...